Delivery Order SPE2DB22D2006-SPE2DB25FW3HL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,842.64 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will be completed by August 14, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Kerendia 10 mg tablets (30-count units). This firm fixed-price delivery order, valued at $15,382.34, was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $24,071.89 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units). This firm fixed-price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $3,984.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). The contract, which is not set-aside and was competitively awarded, is scheduled for completion by August 11, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $14,416.67 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (quantity: 30 count) with an ultimate completion date of August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, awarded competitively on August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,954.02 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,212.34 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order fulfilled by the prime contractor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a $2,376.01 firm fixed-price delivery order by the Defense Logistics Agency on July 22, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a non-set-aside competitive award with a completion date of July 23, 2025. The contract is performed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) with a ceiling value of $2,330.76. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Kerendia 10 mg tablets (90-count units) with a ceiling value of $6,552.19. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and is classified as a non-set-aside contract, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3HLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $6,857.16, was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million through December 2026. The SPE2DX serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its role as a critical vendor for the Defense Health Agency and other government healthcare systems, delivering specialized medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Department of Defense and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 8/11/25 |